Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0941 vs Glimepiride in T2DM on Metformin
NCT00792935Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mk-0941 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Jan 2009; status: completed.
02
Drugs
mk-0941
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00792935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792935.